17th August 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

AstraZeneca India announced a partnership with Alveofit, a respiratory healthcare platform, to offer IoT-enabled handheld spirometers in hospitals across the country.

Sanofi has halted further development of amcenestrant, a treatment once thought to have strong commercial potential in breast cancer, after a second trial failure dealt a major blow to the French healthcare company’s development prospects.

Sun Pharma's Mohali facility receives six USFDA observations

Sun Pharmaceutical Industries Limited recently announced that the US Food and Drug Administration completed an inspection at the company’s Mohali manufacturing facility, resulting in six observations.

 

USFDA approved Aurobindo Pharma Arm's Vasopressin Injection

Aurobindo Pharma Limited announced that its wholly owned subsidiary company, Eugia Pharma Specialties Limited, has received final FDA approval to manufacture and market Vasopressin Injection USP, 20 Units/mL Multiple-Dose Vials.

HP's pharma units and stockists scrutinized by task force

Anti-narcotics task force (ANTF) raids have recently been conducted on 42 pharmaceutical production units, chemist shops, and wholesalers across Himachal Pradesh.

Wipro GE Healthcare, & Boston Scientific formed partnership to provide cardiac care solutions in India

Wipro GE Healthcare announced that it has partnered with medical device maker Boston Scientific to provide end-to-end innovative interventional cardiac care solutions in India.

StanPlus collaborates with Narayana Hrudayalaya to expand emergency medical response in Bengaluru

StanPlus recently announced a partnership with Narayana Hrudayalaya Ltd to manage its ambulance services and provide critical care in less than 15 minutes.

Drug producers in Bangladesh seeking for TRIPS waiver to be extended until 2033

Bangladesh drug makers and business leaders have stated that the intellectual property rights waiver for the pharmaceutical industry must be extended until 2033, six years after the country’s graduation from least developed country status in late 2026. 

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Welcome to PharmaState Academy

Install
×
Start chat
1
Need Help?
PharmaState Academy
Hello, how can we help you?